PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40086820,"Optimization of Adcitmer, a Monomethyl-Auristatin E bearing antibody-drug conjugate for the treatment of CD56-expressing cancers.",2025 Mar 13,Baltus Christine B; Desgranges Audrey; Viaud-Massuard Marie Claude,McSAF,drouin.aurelie37@gmail.com
40086733,Redefining Clinical Trial Strategic Design to Support Drug Approval in Medical Oncology.,2025 Mar 12,Pérez-García J M,USA),javier.cortes@maj3.health
40086472,Delphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severity.,2025 Mar 12,Aquilano Michele,Centro di Radiochirurgia Cyberknife IFCA- Casa di Cura Villa Ulivella e Glicini,julie_ryan@urmc.rochester.edu
40086453,Prevention and control of HPV-related cancers in people living with HIV.,2025 Mar 11,Clifford Gary,International Agency for Research on Cancer,anneli.uuskula@ut.ee
40085959,Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.,2025 Mar 14,Kok Chung Hoow,SA Pathology,
40084656,The value of real-world evidence in supporting targeted therapies for patients with rare oncogenic drivers in mNSCLC.,2025 Mar 14,Berk Alexandra; Abrahami Devin,Pfizer Inc; USA,
40084273,Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML.,2025 Mar 20,Gómez-Cebrián Nuria; Puchades-Carrasco Leonor; Vanrell Lucía,Instituto de Investigación Sanitaria La Fe (IIS La Fe); Nanogrow Biotech,
40084161,Independent Review Organization and Proton Therapy: Multistate Analysis and Legal Procedural Strategies.,2025 Mar,Brooks Eric D; Turner Montreal; Vergara Noreen K; Palmer Matthew,LLC; Kansas City; USA,
